Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novavax Inc
(NQ:
NVAX
)
16.44
+1.32 (+8.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novavax Inc
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
54
55
Next >
10 Health Care Stocks With Whale Alerts In Today's Session
April 07, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Vaccine Makers Down on FDA Meeting, Novavax Most at Risk
April 07, 2022
The major covid-19 vaccine makers are all down, anticipating bad-for-business news from the FDA. However, NVAX stock has the most to lose.
Via
InvestorPlace
Dear Biotech Investors: Novavax’s Comparable Vaccine Matters
April 07, 2022
Researchers compared Novavax’s vaccine to three others on the market, offering a thorough glimpse of protection from boosters.
Via
InvestorPlace
FDA Official Says Frequent COVID-19 Booster Shows Not Sustainable: WSJ
April 07, 2022
According to a U.S. health regulator, asking people to get COVID-19 boosters frequently wasn't sustainable because of vaccine fatigue, and authorities needed to develop a long-term strategy for...
Via
Benzinga
Is NVAX Stock a Buy at 52-Week Low? Skip the Novavax Portfolio Injection
April 06, 2022
NVAX stock could slide even further as research & development requirements stack up against its balance sheet's capacity.
Via
InvestorPlace
Why Is Novavax (NVAX) Stock Down Today?
April 05, 2022
Today, investors in Novavax and NVAX stock appear to be spooked by some key rhetoric from Dr. Anthony Fauci regarding vaccinations.
Via
InvestorPlace
The Waiting Game Is Wearing Thin for Novavax Investors
April 01, 2022
If you’re not otherwise engaged with NVAX stock, it’s best to wait until the picture gets clearer on EUA approval.
Via
InvestorPlace
Novavax's COVID-19 Vaccine Scores Green Light In India with First Approval For Adolescents
March 23, 2022
Via
Benzinga
Novavax Just Hit A New Yearly Low, Here’s How To Buy It Even Lower
April 06, 2022
NVAX stock is still falling. Get paid for your patience to be a buyer at lower levels by selling expensive puts.
Via
InvestorPlace
Don’t Bet on New Highs for Novavax Stock
April 06, 2022
Investors would do well to avoid repeating the mistake of expecting moonshots in NVAX stock. The business may do better, but the stock won't.
Via
InvestorPlace
4 Top Stock Trades for Wednesday: Dogecoin, NVDA, TLRY, NVAX
April 05, 2022
Dogecoin, Nvidia, Tilray and Novavax were our top stock trades for Wednesday. Here's how the charts are setting up now.
Via
InvestorPlace
What's Going On With Novavax Shares Today?
April 05, 2022
Novavax Inc (NASDAQ: NVAX) shares are trading significantly lower Tuesday. According to data from Benzinga Pro, Tuesday's trading volume is in line with Novavax's average trading volume over a 100-day...
Via
Benzinga
Novavax Has More Upside Ahead, as Covid-19 Shots Hit the Market
April 05, 2022
After Covid-19 vaccine delivery and regulatory woes, there is finally more upside than downside risks with NVAX stock.
Via
InvestorPlace
What to Make of Novavax’s Adolescent Covid-19 Vaccine Move
April 05, 2022
NVAX stock foray in the adolescent Covid-19 vaccine market could pay dividends but investors should tread with caution at this time.
Via
InvestorPlace
Novavax’s First Canadian Shipments Are Boosting NVAX Stock
April 04, 2022
Novavax delivered its first shipments to Canadian health authorities last week, and the news continues to help NVAX stock climb higher today.
Via
InvestorPlace
Novavax Stock Is Alluringly Attractive at This Stage
April 04, 2022
Novavax is close to securing FDA approval for its Covid-19 vaccine, yet NVAX stock is down since the end of January. What gives?
Via
InvestorPlace
10 Investor Questions About COVID-19, Answered
April 03, 2022
The COVID-19 outbreak has finally subsided in the U.S., but biotech investors still have plenty of lingering questions about the virus and what to expect in the months and years ahead. On Thursday,...
Via
Benzinga
How to Approach Trading Downtrodden Novavax Today
April 01, 2022
There are obvious reasons to be bearish on NVAX stock's price chart, but a word to the wise would include the use of this type of put spread.
Via
InvestorPlace
Mitt Romney Says Senators Reached Tentative $10B Deal In Additional COVID-19 Relief Funding: CNBC
April 01, 2022
Via
Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
March 31, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Omicron More Severe For Unvaccinated Children Than Other Strains, Hong Kong Study Finds: Bloomberg
March 31, 2022
According to a Hong Kong-based study, the omicron variant of COVID-19 has been linked to more hospitalizations, severe complicat
Via
Benzinga
If You Invested $1000 In Novavax 5 Years Ago, Here's How Much You Would Have Today
March 30, 2022
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 12.42% on an annualized basis producing an average annual return of 26.64%. Currently, Novavax has a market capitalization of...
Via
Benzinga
EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine
March 30, 2022
Via
Benzinga
Novavax Stock Is a Bet on Interest From Unvaccinated People
March 30, 2022
NVAX stock represents a vaccine that lacks approval. There is real appeal behind the narrative, as it may appeal to unvaccinated people.
Via
InvestorPlace
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness
March 29, 2022
President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country
Via
Benzinga
Looking At Novavax's Recent Whale Trades
March 28, 2022
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Why Most Kids Did Not Suffer Badly Due To COVID-19 Infection? Scientists Look To Solve Mystery: CNBC
March 24, 2022
The COVID-19 pandemic has led to over 6 million fatalities. The scientists are still studying why most children do not suffer badly from coronavirus infection.
Via
Benzinga
5 Cheap Energy Stocks Riding Oil Higher
March 23, 2022
Energy is understandably at the top of every investor's mind right now, but finding the best energy stocks requires careful consideration.
Via
InvestorPlace
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
March 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Novavax’s Success Depends on the FDA’s Decision
March 23, 2022
While Novavax awaits FDA approval, the frustration amongst investors is rising and a lot is on stake. Take a small position in NVAX stock.
Via
InvestorPlace
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.